Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Farnesyltransferase (FTase) is an enzyme that catalyzes the post-translational modification of proteins by attaching a farnesyl lipid group to a cysteine residue near the C-terminus of target proteins. This process, known as farnesylation, is essential for the function and membrane localization of many signaling proteins, most notably members of the Ras superfamily. Inhibition of FTase is a potential therapeutic strategy for cancer.
Farnesyltransferase inhibitors bind to the active site of FTase, preventing the transfer of a farnesyl group from farnesyl pyrophosphate (FPP) to target proteins with a CaaX motif.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Farnesyltransferase (FTase).